Interleukin (IL)-1beta maturation is accomplished by caspase-1-mediated proteolysis, an essential element of innate immunity. NLRs constitute a recently recognized family of caspase-1-activating proteins, which contain a nucleotide-binding oligomerization domain and leucine-rich repeat (LRR) domains and which assemble into multiprotein complexes to create caspase-1-activating platforms called "inflammasomes." Using purified recombinant proteins, we have reconstituted the NALP1 inflammasome and have characterized the requirements for inflammasome assembly and caspase-1 activation. Oligomerization of NALP1 and activation of caspase-1 occur via a two-step mechanism, requiring microbial product, muramyl-dipeptide, a component of peptidoglycan, followed by ribonucleoside triphosphates. Caspase-1 activation by NALP1 does not require but is enhanced by adaptor protein ASC. The findings provide the biochemical basis for understanding how inflammasome assembly and function are regulated, and shed light on NALP1 as a direct sensor of bacterial components in host defense against pathogens.
Huntington disease (HD) is an inherited and incurable neurodegenerative disorder caused by an abnormal polyglutamine (polyQ) expansion in huntingtin (HTT). PolyQ length determines disease onset and severity with a longer expansion causing earlier onset. The mechanisms of mutant HTT-mediated neurotoxicity remain unclear; however, mitochondrial dysfunction is a key event in HD pathogenesis1,2. Here we tested whether mutant HTT impairs the mitochondrial fission/fusion balance and thereby causes neuronal injury. We show that mutant HTT triggers mitochondrial fragmentation in neurons and fibroblasts of HD individuals in vitro and HD mice in vivo before the presence of neurological deficits and HTT aggregates. Interestingly, mutant HTT abnormally interacts with the mitochondrial fission GTPase dynamin-related protein 1 (DRP1) in HD mice and individuals which in turn stimulates its enzymatic activity. Importantly, mutant HTT-mediated mitochondrial fragmentation, defects in anterograde and retrograde mitochondrial transport, and neuronal cell death are all rescued by reducing DRP1 GTPase activity with the dominant-negative DRP1K38A mutant. Thus, DRP1 might represent a new therapeutic target to combat neurodegeneration in HD.
The actin-related protein 2/3 (Arp2/3) complex mediates the formation of branched actin filaments at the leading edge of motile cells and in the comet tails moving certain intracellular pathogens. Crystal structures of the Arp2/3 complex are available, but the architecture of the junction formed by the Arp2/3 complex at the base of the branch was not known. In this study, we use electron tomography to reconstruct the branch junction with sufficient resolution to show how the Arp2/3 complex interacts with the mother filament. Our analysis reveals conformational changes in both the mother filament and Arp2/3 complex upon branch formation. The Arp2 and Arp3 subunits reorganize into a dimer, providing a short-pitch template for elongation of the daughter filament. Two subunits of the mother filament undergo conformational changes that increase stability of the branch. These data provide a rationale for why branch formation requires cooperative interactions among the Arp2/3 complex, nucleation-promoting factors, an actin monomer, and the mother filament.
Despite their importance as signaling hubs, the function of mitochondria-ER contact sites in mitochondrial quality control pathways remains unexplored. Here we describe a mechanism by which Mfn2, a mitochondria-ER tether, gates the autophagic turnover of mitochondria by PINK1 and parkin. Mitochondria-ER appositions are destroyed during mitophagy, and reducing mitochondria-ER contacts increases the rate of mitochondrial degradation. Mechanistically, parkin/PINK1 catalyze a rapid burst of Mfn2 phosphoubiquitination to trigger p97-dependent disassembly of Mfn2 complexes from the outer mitochondrial membrane, dissociating mitochondria from the ER. We additionally demonstrate that a major portion of the facilitatory effect of p97 on mitophagy is epistatic to Mfn2 and promotes the availability of other parkin substrates such as VDAC1. Finally, we reconstitute the action of these factors on Mfn2 and VDAC1 ubiquitination in a cell-free assay. We show that mitochondria-ER tethering suppresses mitophagy and describe a parkin-/PINK1-dependent mechanism that regulates the destruction of mitochondria-ER contact sites.
p97 (also called VCP), a member of the AAA ATPase family, is involved in several cellular processes, including membrane fusion and extraction of proteins from the endoplasmic reticulum for cytoplasmic degradation. We have studied the conformational changes that p97 undergoes during the ATPase cycle by cryo-EM and single-particle analysis. Three-dimensional maps show that the two AAA domains, D1 and D2, as well as the N-domains, experience conformational changes during ATP binding, ATP hydrolysis, P(i) release and ADP release. The N-domain is flexible in most nucleotide states except after ATP hydrolysis. The rings formed by D1 and D2 rotate with respect to each other, and the size of their axial openings fluctuates. Taken together, our results depict the movements that this and possibly other AAA ATPases can undergo during an ATPase cycle.
Formin proteins are regulators of actin dynamics, mediating assembly of unbranched actin filaments. These multidomain proteins are defined by the presence of a Formin Homology 2 (FH2) domain. Previous work has shown that FH2 domains bind to filament barbed ends and move processively at the barbed end as the filament elongates. Here we report that two FH2 domains, from mammalian FRL1 and mDia2, also bundle filaments, whereas the FH2 domain from mDia1 cannot under similar conditions. The FH2 domain alone is sufficient for bundling. Bundled filaments made by either FRL1 or mDia2 are in both parallel and anti-parallel orientations. A novel property that might contribute to bundling is the ability of the dimeric FH2 domains from both FRL1 and mDia2 to dissociate and recombine. This property is not observed for mDia1. A difference between FRL1 and mDia2 is that FRL1-mediated bundling is competitive with barbed end binding, whereas mDia2-mediated bundling is not. Mutation of a highly conserved isoleucine residue in the FH2 domain does not inhibit bundling by either FRL1 or mDia2, but inhibits barbed end activities. However, the severity of this mutation varies between formins. For mDia1 and mDia2, the mutation strongly inhibits all effects of barbed end binding, but affects FRL1 much less strongly. Furthermore, our results suggest that the Ile mutation affects processivity. Taken together, our data suggest that the bundling activities of FRL1 and mDia2, while producing phenotypically similar bundles, differ in mechanistic detail.Formin proteins have emerged as important actin filament assembly factors. Mammals have 15 formin isoforms, which segregate into seven distinct groups based on Formin Homology 2 (FH2) 3 domain phylogeny (1). The FH2 domain is the defining structural feature of this family, and is responsible for most formin effects on actin. A key functional feature is that the FH2 domain is dimeric (2-5). Studies on the Bni1p FH2 domain from budding yeast show that this dimer has no measurable ability to dissociate (5).For all formins studied to date, the FH2 domain binds tightly to the actin filament barbed end, and moves processively as the barbed end elongates. This ability appears to mediate three effects: 1) polymerization acceleration, 2) alteration of elongation/depolymerization rates, and 3) protection of barbed ends from capping protein (reviewed in Ref. 6). In addition to barbed end binding, some formins can also bind actin filament sides (3) and bundle filaments (7,8).Recent structural studies have greatly advanced our understanding of how formins associate with filament barbed ends. The crystal structure of the Bni1p FH2 domain shows it to be a "donut shaped" anti-parallel dimer, with a central hole created by two sets of dimerization interactions between subunits (5). Mutational analysis reveals that surfaceexposed residues on the interior of the donut are necessary for Bni1p-mediated actin assembly and protection from capping protein. This dimer is very stable, but flexible because of an extende...
A vesicle system is described that possesses a pH-induced "breathing" feature and consists of a three-layered wall structure. The "breathing" feature consists of a highly reversible vesicle volume change by a factor of ca. 7, accompanied by diffusion of species into and out of the vesicles with a relaxation time of ca. 1 min. The triblock copolymer poly(ethylene oxide)(45)-block-polystyrene(130)-block-poly(2-diethylaminoethyl methacrylate)(120) (PEO(45)-b-PS(130)-b-PDEA(120)) was synthesized via ATRP. Self-assembly into vesicles was carried out at a pH of ca.10.4. The vesicle wall was shown by cryo-TEM to consist of a sandwich of two external ca. 4 nm thick continuous PS layers and one ca. 17 nm thick PDEA layer in the middle. As the pH decreases, both the vesicle size and the thickness of all three layers increase. The increase of the thickness of the intermediate PDEA layer arises from the protonation and hydration, but the swelling is constrained by the PS layers. The increase of the thickness of the two PS layers is a result of an increasing incompatibility and an accompanying sharpening of the interface between the PS layers and the PDEA layer. Starting at a pH slightly below 6, progressive swelling of the PDEA layer with decreasing pH induces a cracking of the two PS layers and also a sharp increase of the vesicle size and the wall thickness. By pH 3.4, the vesicle size has increased by a factor of approximately 1.9 and the wall shows a cracked surface. These changes between pH 10.4 and 3.4 are highly reversible with the relaxation time of ca. 1 min and can be performed repeatedly. The change in the wall structure not only increases dramatically the wall permeability to water but also greatly expands the rate of proton diffusion from practically zero to extremely rapid.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.